Open AccessThe Effect of Transdermal Testosterone on Mammographic Density in Postmenopausal Women Not Receiving Systemic Estrogen Therapy
Author(s) -
Susan R. Davis,
Angelica Lindén Hirschberg,
L. Wagner,
Imran Lodhi,
Bo von Schoultz
Publication year - 2009
Publication title -
the journal of clinical endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.206
H-Index - 353
eISSN - 1945-7197
pISSN - 0021-972X
DOI - 10.1210/jc.2009-1523
Subject(s) - medicine , placebo , context (archaeology) , menopause , testosterone (patch) , hormone replacement therapy (female to male) , estrogen , progestin , body mass index , urology , hormone therapy , endocrinology , breast cancer , transdermal , gynecology , cancer , pharmacology , pathology , paleontology , alternative medicine , biology
Greater mammographic density is associated with increased breast cancer risk and reduced diagnostic mammographic sensitivity and may be seen with estrogen/progestin therapy (EPT). The effects of testosterone therapy on mammographic density in postmenopausal women not on EPT are not known.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom